Tag: genetic toxicology testing market analysis

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Genetic Toxicology Testing Market from 2024 to 2033?
The genetic toxicology testing market has seen rapid growth, expected to rise from $1.48 billion in 2023 to $1.63 billion in 2024 at a CAGR of 10%. This growth is driven by public health crises, increasing globalization, a focus on personalized medicine, rising demand for thorough testing solutions, and a growing number of drugs.

The genetic toxicology testing market is expected to see rapid growth, reaching $2.4 billion by 2028, with a CAGR of 10.2%. Growth is driven by the demand for testing novel foods, health concerns, regulatory scrutiny, and the rise of in vitro testing methods. Key trends include advancements in precision medicine, risk communication, testing methodologies, risk assessment, omics technology integration, and genomics advancements.

Claim Your Free Sample of the Global Genetic Toxicology Testing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Key Factors Are Fueling the Growth of the Genetic Toxicology Testing Market?
The increasing demand for personalized medicine is expected to enhance the growth of the genetic toxicology testing market. Personalized medicine tailors healthcare based on individual responses and disease risks. The market is growing due to genetic advancements and biomarker diagnostics. Genetic toxicology testing provides insights into genetic variability and treatment responses. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized medicines in 2023, up from six in 2022. Thus, the rising demand for personalized medicine is driving the genetic toxicology testing market.

What Are the Major Segments of the Genetic Toxicology Testing Market?
1) By Type: In Vitro; In Vivo
2) By Product: Services; Reagents And Consumables; Assays
3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications

What New Trends Are Transforming the Genetic Toxicology Testing Market?
Major companies in the genetic toxicology testing market are innovating drug screening platforms like phenotypic drug screening. In August 2022, Creative Biogene, a US biotech firm, introduced zebrafish disease models for drug discovery and toxicology research.

Order Now for Fast Delivery of Your Genetic Toxicology Testing Market Report!
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Regions Are Driving Growth in the Genetic Toxicology Testing Market?
North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Genetic Toxicology Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the genetic toxicology testing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Genetic Toxicology Testing Market Include

1. Genetic Toxicology Testing Market Executive Summary
2. Genetic Toxicology Testing Market Segments
3. Genetic Toxicology Testing Market Size And Template Market Growth Rate
4.  Key Genetic Toxicology Testing Market Trends
5. Major Genetic Toxicology Testing Market Drivers
……
25. Key Mergers And Acquisitions In The Genetic Toxicology Testing Market
26. Top Genetic Toxicology Testing Companies
27. Genetic Toxicology Testing Market Opportunities And Strategies
28. Genetic Toxicology Testing Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Genetic Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Direct-To-Consumer (Dtc) Genetic Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

In-Vitro Toxicology Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Genetic Toxicology Global Market Report 2023, the genetic toxicology market is expected to show significant growth in the forecast period.

Market Overview

• Significant growth in recent years: The genetic toxicology testing market grew from $1.48 billion in 2023 to $1.63 billion in 2024, with a 10% CAGR.
• Projected expansion: By 2028, the market is expected to reach $2.4 billion, growing at a 10.2% CAGR.

Historical Growth Drivers

• Public health crises: Rising health concerns have fueled the demand for genetic toxicology testing.
• Globalization: Increased cross-border trade necessitates rigorous testing solutions.
• Personalized medicine: A focus on tailored healthcare has led to more genetic testing.
• Drug development: The growing number of drugs requires extensive genetic toxicity testing.

View More On The Genetic Toxicology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Future Growth Drivers

• Testing for novel foods: Rising concerns about food safety will drive demand for genetic toxicology testing.
• Environmental and health concerns: Increased awareness of environmental risks will boost the market.
• Regulatory scrutiny: Stricter regulations will lead to more rigorous testing protocols.
• In vitro methods: These methods are increasingly being adopted for their efficiency.
• High-throughput screening: The rise of these platforms will enhance testing capabilities.

Role of Personalized Medicine

• Demand surge: Personalized medicine, which tailors treatments to individual patients, is a significant growth driver.
• Genetic breakthroughs: Advances in genetics have fueled the rise of personalized medicine.
• FDA approvals: In 2023, the FDA approved 16 new personalized medicines, up from six in 2022.
• Impact on genetic toxicology: This testing provides critical data on genetic variability and treatment responses, supporting personalized medicine initiatives.

Major Market Players

• Key companies: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, and others dominate the market.
• Focus on innovation: Companies are developing new drug screening platforms to enhance testing accuracy.

Innovations in Drug Screening

• Phenotypic drug screening: A method focusing on the effects of compounds in living organisms is revolutionizing the market.
• Creative Biogene’s zebrafish models: Launched in August 2022, these models support drug discovery and toxicology research, offering a platform to assess drug toxicity.

Strategic Acquisitions

• Charles River Laboratories and Vigene Biosciences: In June 2021, Charles River acquired Vigene Biosciences for $292.5 million, expanding its gene therapy capabilities.
• Focus on CDMO sectors: The acquisition bolsters Charles River’s presence in the cell and gene therapy contract development and manufacturing organization sectors.

Market Segmentation

• By Type: In Vitro, In Vivo.
• By Product: Services, Reagents and Consumables, Assays.
• By Application: Healthcare, Food, Cosmetics, Agriculture, and other industries.

Regional Insights

• North America: The largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

Request A Sample Of The Global Genetic Toxicology Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15574&type=smp